期刊文献+

心脏移植术后的骨质疏松症 被引量:1

Osteoporosis after cardiac transplantation
原文传递
导出
摘要 目的研究心脏移植后患者的骨质疏松症的发病情况。方法采用双能X线吸收扫描仪(DXA)测定53例心脏移植患者和22例准备接受心脏移植患者的腰椎和股骨颈的骨矿密度(BMD)。结果22例未手术者的腰椎和股骨颈的BMD基本正常,其Z值均匀紧密地分布在0值周围。53例心脏移植患者术后腰椎和股骨颈的BMD下降,其Z值出现明显的左移,8例患者出现腰椎骨质疏松,他们的股骨颈的BMD也同时下降。术后患者的BMD降低主要在术后2年以内。结论心脏移植术后患者可出现BMD下降,严重者可出现骨质疏松症,其发病主要与术后长期使用肾上腺皮质激素和环孢素A有密切关系。 Objective To study the prevalence of osteoporosis in patients undergoing cardiac transplantation.Methods By using dual energy X ray absorptiometry, bone mineral density(BMD) in lumbar spine and femoral neck was measured in 53 adult patients after cardiac transplantation and 22 patients prior to heart transplantation.Results Mean BMD in lumbar spine and femoral neck was roughly one standard deviation below the mean for age matched and sex matched subjects both for men and women. Eight patients( 15.1% ) had densitometric evidence of osteopenia defined as a Z score of - 2.0 SD or less. The mean BMD in lumbar spine and femoral neck was normal in 22 patients without undergoing cardiac transplantation. The most rapid drop in vertebral BMD occurred during the first 2 years following cardiac transplantation.Conclusion Osteopenia are common in the patients after cardiac transplantation, which might be related to the immunosuppressive therapy-glucocorticoid and cyclosporine A.
出处 《中华器官移植杂志》 CAS CSCD 1999年第1期56-58,共3页 Chinese Journal of Organ Transplantation
关键词 心脏/移植 骨质疏松 肾上腺皮质激素类 环孢素类 Heart/transplantation Osteoporosis Adrenal cortex hormones Cyclosporins
  • 相关文献

同被引文献62

  • 1Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U. S . Unit- ed Network of Organ Sharing data, 1990 to 2005[J]. J Am Coil Cardiol,2007,50(13): 1282-1290.
  • 2American College of Sports Medicine.ACSM's exercise man- agement for persons with chronic diseases and disabilities [M].2nd ed. 2003: 713-75.
  • 3Kavanagh T, Yacoub MH, Mertens DJ, et al.Cardiorespiratory responses to exercise training after orthotopic cardiac trans- plantation[J]. Circulation, 1988,77(1): 162-171.
  • 4Braith RW,Wood CE,Limaeher MC,et al.Abnormal neuroendo- crine responses during exercise in heart transplant recipients [J]. Circulation,1992,86(5): 1453-1463.
  • 5Lukert B. Glucocorticoid-induced osteoporosis. In: Marcus R, Feldman D, Kelsey J, Eds. Osteoporosis. San Diego, Academ- ic Press 1996.
  • 6Kapetanakis El, Antonopoulos AS, Antoniou TA,et al. Effect of long-term calcitonin administration on steroid-induced os- teoporosis after cardiac transplantation[J]. Journal of Heart & Lung Transplantation,2005,24(5):526-532.
  • 7Yong G,Hayes H,O'Driscoll G. Strategy of aggressive steroid weaning and routine alendronate therapy to reduce bone loss after cardiac transplantation[J]. Transplantation Proceedings, 2007,39(10):3340-3343.
  • 8Keteyian S, Shepard R, Ehrman J, et al.Cardiovascular re- sponses of heart transplant patients to exercise training[J]. Journal of Applied Physiology,1991,70 (6): 2627-2631.
  • 9Ehrman J, Keteyian S, Fedel F, et al.Ventilatory threshold after exercise training in orthotopic heart transplant recipients [J].Joumal of Cardiopulmonary Rehabilitation,1992,12:126-13.
  • 10Shephard RJ, Kavanagh T, Mertens D J, et al.The place of perceived exertion ratings in exercise prescription for cardi- ac transplant patients before and after training[J]. BR J Sports Med,1996,30:116-121.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部